Sage Therapeutic Com (SAGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2025 | 03-2025 | 12-2024 | 09-2024 | 06-2024 | |
| Sales | 31,660 | 14,063 | 12,816 | 11,871 | 8,654 |
| Cost of Goods | -55 | 655 | 1,490 | 5,278 | 1,407 |
| Gross Profit | 31,715 | 13,408 | 11,326 | 6,593 | 7,247 |
| Operating Expenses | 85,629 | 81,518 | 114,009 | 108,073 | 118,954 |
| Operating Income | -53,969 | -67,455 | -102,193 | -101,202 | -111,300 |
| Other Income | 4,317 | 5,241 | 6,415 | 7,651 | 8,446 |
| Pre-tax Income | -49,652 | -62,214 | -95,778 | -93,551 | -102,854 |
| Net Income Continuous | -49,652 | -62,214 | -95,778 | -93,551 | -102,854 |
| Net Income | $-49,652 | $-62,214 | $-95,778 | $-93,551 | $-102,854 |
| EPS Basic Total Ops | -0.79 | -1.01 | -1.56 | -1.53 | -1.70 |
| EPS Basic Continuous Ops | -0.79 | -1.01 | -1.56 | -1.53 | -1.70 |
| EPS Diluted Total Ops | -0.79 | -1.01 | -1.56 | -1.53 | -1.70 |
| EPS Diluted Continuous Ops | -0.79 | -1.01 | -1.56 | -1.53 | -1.70 |
| EPS Diluted Before Non-Recurring Items | N/A | -1.01 | -1.56 | -1.53 | -1.70 |
| EBITDA(a) | $-54,307 | $-68,324 | $-103,007 | $-102,994 | $-112,926 |